POLYVANTIS Implements Solar Energy in Germany, Reducing Carbon Footprint by Over 750 Metric Tons Annually
POLYVANTIS announces the commissioning of approximately 3.3 GWh of solar energy for its Weiterstadt, Germany, manufacturing location. The company will reduce its carbon (CO₂) footprint by 750 metric tons annually through the implementation of solar energy. This savings is equivalent to the energy required to run over 900 households*.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250406553777/en/
Photo of solar panels alongside POLYVANTIS facility in Weiterstadt, Germany
Innovating for Sustainable Improvement
"The installation of the solar park is an important step toward a resource-efficient future and underscores our commitment to innovating for the future," says Reinhard Tag, EVP of Manufacturing for POLYVANTIS. "Through utilizing state-of-the-art methods such as solar energy, we are creating a future that promotes sustainable practices for our manufacturing operations."
Efficient Use and Sustainable Energy Generation
The state-of-the-art solar plant is located on POLYVANTIS grounds and has an installed capacity of 3.6 MW and an expected annual energy production of approximately 3.3 GWh, making a significant contribution to sustainable electricity supply. Approximately 10% of the whole electric power consumption of the Weiterstadt site will be replaced with energy from the solar park.
Outlook on Future Projects
The commissioning of this plant marks another milestone in POLYVANTIS's sustainable strategy. Future projects are planned to continue expanding renewable energy sources.
*Source: German Federal Network Agency for electricity, gas, telecommunications, Post and Railways
About POLYVANTIS
POLYVANTIS is a global, multi-material player with some of the most coveted and iconic brands in the industry – such as PLEXIGLAS® and ACRYLITE® for polymethylmethacrylate semi-finished products and LEXAN™ for polycarbonate sheets and films. With 1,500 employees and 15 production sites worldwide, POLYVANTIS offers unmatched global capabilities, providing customers with innovative solutions in sheets and films for the building and construction, electrical and electronics, automotive, air and rail, healthcare and security, and lighting and signage markets. To learn more about the latest at POLYVANTIS, follow us on LinkedIn or our website.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250406553777/en/
Contacts
Media Inquiries:
Amy Waterman
Director, Global Marketing and Communications
amy.waterman@polyvantis.net
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution15.12.2025 14:05:00 CET | Press Release
Novotech, a leading global full-service clinical research organization (CRO) and scientific advisory company, has released a new white paper, Early-Phase Oncology – Clinical Research Landscape and CRO Enablers (2025), offering in-depth analysis of the key drivers shaping early-phase oncology development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215843975/en/ With approximately 60% of oncology agents progressing from Phase I to Phase II, but only 3–6% reaching regulatory approval, the paper outlines the factors influencing early-stage success, including trial design, patient selection, and regional development pathways. The paper highlights Australia’s continued position as a global first-in-human (FIH) and early-phase research hub. Its ethics-led review frameworks, which can support trial initiation within roughly 4–8 weeks, combined with established FIH centers, oncology networks, and cost efficiencies, position Au
Ant Group Announces Major Upgrades to Its 15-Million-MAU AI Health App AQ Amid Wider Push into Health Sector15.12.2025 14:03:00 CET | Press Release
Ant Group today announced major upgrades to its AI health app AQ, with a new Chinese name “Ant A-Fu.” The character “Fu” conveys good wishes and well-being, reflecting the app’s goal to promote better health and quality of life. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215203213/en/ Ant Group’s AI health app AQ features three core capabilities: health Q&A, AI health companion, and integrated health services. The upgraded version of AQ now features three core capabilities: health Q&A, AI health companion, and integrated health services. Launched in June 2025, AQ has rapidly grown to 15 million monthly active users, making it China’s leading AI health management app. Positioned as an AI health companion service, AQ currently answers over 5 million health-related questions every day. The announcement comes amid China’s ongoing demographic shift. According to projections from the National Health Commission, by around 20
Copeland and Daikin Cooperation Brings Solutions to European Customers15.12.2025 14:00:00 CET | Press Release
Copeland and Daikin, two global leaders in heating, ventilation and air conditioning (HVAC) solutions, today announced the expansion of their existing joint venture into Europe. Through this cooperation, the companies will introduce advanced inverter swing rotary compressors, power electronics and controls designed specifically for European residential heat pumps. This collaboration underscores both companies’ commitment to accelerate the energy transition, with heat pumps recognized by industry reports as a cornerstone technology helping to reduce global carbon dioxide emissions by an estimated 500 million tons by 2030. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251215625806/en/ (Left to right) Ross B. Shuster, CEO of Copeland and Jiro Tomita, executive associate officer of Daikin As Europe rapidly transitions away from fossil fuels, the demand for residential heat pumps is growing in parallel with ambitious sustainabil
Visa Unveils New Global Stablecoins Advisory Practice15.12.2025 13:00:00 CET | Press Release
Visa (NYSE: V), a global leader in digital payments, today announced the launch of its Stablecoins Advisory Practice. The new value-added service offering by Visa Consulting & Analytics (VCA) provides actionable insights and recommendations to guide banks, fintechs, merchants, and businesses of all sizes on market fit, strategy, and implementation. As the stablecoin market cap surpasses $250 billion, Visa’s settlement volume has accelerated, reaching a $3.5 billion annualized run rate as of November 30. Businesses are turning to Visa’s new Stablecoins Advisory Practice to unlock growth opportunities. “Putting our members first has always been our mission, and we’re committed to exploring innovations that strengthen financial health and convenience for those we serve. Stablecoins may represent an opportunity to enhance speed and lower cost in payments, so with the support of Visa, we are evaluating how this technology could fit into our broader strategy to deliver meaningful value to ou
SK Capital Announces Definitive Agreement to Invest in Swixx BioPharma AG to Drive the Next Phase of Growth and Global Expansion15.12.2025 12:30:00 CET | Press Release
SK Capital Partners, LP (“SK Capital”), a New York-based private investment firm focused on the life sciences, specialty materials, and ingredients sectors, today announced that its affiliate has reached an agreement to invest in Swixx BioPharma AG (“Swixx” or the “Company”) to accelerate the Company’s next phase of growth and global expansion. The investment values the Company in excess of EUR €1.5 billion. Swixx is the global leader in rest-of-world pharmaceutical commercialization services dedicated to delivering innovative, life-saving medications to underserved and hard-to-reach markets. Stuart Swanson and Petr Němec, Swixx’s Co-Founders, and Jean-Michel Lespinasse and Petr Pipal, Swixx’s CEO and CFO, respectively, will all retain significant ownership stakes in Swixx as part of the transaction. Existing institutional investors HBM Healthcare Investments, a Swiss-listed investment company for the global healthcare market, and Mérieux Equity Partners, a leading healthcare-specializ
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom